<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fukaya</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Ozaki</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Kamamoto</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Tokuda</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Kimura</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fukuchi</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: a case report</article-title>. 
  <source>Mol Clin Oncol</source>. (
  <year>2016</year>) 
  <volume>5</volume>:
  <fpage>417</fpage>â€“
  <lpage>21</lpage>. 
  <pub-id pub-id-type="doi">10.3892/mco.2016.996</pub-id>
  <?supplied-pmid 27703677?>
  <pub-id pub-id-type="pmid">27703677</pub-id>
 </mixed-citation>
</ref>
